A JACC: Cardiovascular Interventions study published this month suggests machine learning models are more predictive and discriminative than standard methods for identifying patients at the greatest risk of CV mortality and rehospitalization after PCI.

Over the last six years, Dell Technologies Capital has plunked down more than $600 million to invest in startups focused on accelerating the “reinventing work” evolution. Microsoft’s M12 venture fund has shown similar enthusiasm.

Methamphetamine abuse is on the rise among veterans with concomitant heart failure, according to a recent analysis published in the American Journal of Cardiology. 

Often lost in discussions about AI’s unfolding impact on healthcare is its uncertain effect on patient-physician relationships. The authors of an opinion piece published July 15 in JAMA take up a key question underlying this lack.

Industry leaders, including the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Medical Imaging and Technology Alliance (MITA), hosted a Capitol Hill Briefing July 17, to discuss a bipartisan bill that would expand patient access to diagnostic radiopharmaceuticals.

The American College of Radiology (ACR) has issued a statement sharing “serious concerns” with HR 3630, the No Surprises Act, which is currently scheduled to be considered by the House Energy and Commerce Committee.

A newly created three-dimensional (3D) neural network can improve the detection of pulmonary nodules on CT scans, according to a study published July 12 in PLOS ONE. 

Radiologists show more interest in telemedicine job opportunities than representatives from any other specialty, according to a new report published by Doximity.

Clinical decision support (CDS) tools can improve the appropriateness of advanced imaging orders, according to new findings published in the American Journal of Roentgenology. 

Gadobutrol, sold by Bayer under the brand name Gadavist, became the first FDA-approved contrast agent for use in cardiac magnetic resonance imaging on July 15.